Abacus Health Products Inc (OTCMKTS:ABAHF – Get Free Report) dropped 5.1% during trading on Wednesday . The stock traded as low as $4.60 and last traded at $4.84. Approximately 9,300 shares traded hands during trading, a decline of 9% from the average daily volume of 10,164 shares. The stock had previously closed at $5.10.
Abacus Health Products Stock Down 5.1%
The business’s fifty day moving average is $4.84 and its 200-day moving average is $4.84.
About Abacus Health Products
Abacus Health Products (OTCMKTS: ABAHF) is a specialty pharmaceutical company focused on the acquisition, development and commercialization of prescription and over-the-counter (OTC) healthcare products. The company targets established therapeutic areas where existing safety and efficacy data can be leveraged to accelerate regulatory approval and market launch. By sourcing under-commercialized assets or products nearing patent expiry, Abacus aims to extend product lifecycles and deliver value to healthcare providers and consumers.
Abacus’s portfolio is built around topical and consumer-focused formulations, including treatments for dermatological conditions, pain management and common cold or flu symptoms.
Featured Articles
- Five stocks we like better than Abacus Health Products
- Trump’s Hand-Written Letter Will Shock his Haters
- ISPC: From Small Cap to Life Sciences Market Disruptor!
- The Crash Has Already Started (Most Just Don’t See It Yet)
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- Wall Street Legend Names #1 Stock of 2026 Live On-Camera
Receive News & Ratings for Abacus Health Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abacus Health Products and related companies with MarketBeat.com's FREE daily email newsletter.
